Ratings by H.C. Wainwright (Joseph Pantginis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/11/2024 | Alpine Immune Sciences | ALPN | Downgrade | Neutral (Buy) |
47.04 (64.49) |
37.1% | Details | |
| 4/9/2024 | Biora Therapeutics | BIOR | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2024 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2024 | Panbella Therapeutics | PBLA | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2024 | Alpine Immune Sciences | ALPN | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | BiomX | PHGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2024 | CalciMedica | CALC | New Coverage | Buy (N/A) |
5.57 (4.01) |
-28.01% | Details | |
| 12/28/2023 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2023 | Alpine Immune Sciences | ALPN | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2023 | Cadrenal Therapeutics | CVKD | New Coverage | Buy (N/A) |
0.47 (0.40) |
-14.89% | Details | |
| 11/8/2023 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2023 | VYNE Therapeutics | VYNE | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2023 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2023 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2023 | Biora Therapeutics | BIOR | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2023 | Bionomics Ltd. | BNOX | Upgrade | Buy (Neutral) |
0.99 (0.98) |
-1.01% | Details | |
| 9/15/2023 | BioLineRx | BLRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Alpine Immune Sciences | ALPN | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Atreca Inc. | BCEL | Downgrade | Neutral (Buy) |
0.88 (0.15) |
-82.95% | Details | |
| 8/9/2023 | XOMA, Ltd. | XOMA | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Aravive Inc. | ARAV | Downgrade | Neutral (Buy) |
1.28 (0.04) |
-96.88% | Details | |
| 6/26/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2023 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2023 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2023 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2023 | Mustang Bio | MBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2023 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | BiomX | PHGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | Xenetic Biosciences | XBIO | Downgrade | Neutral (Buy) |
3.31 (4.20) |
26.89% | Details | |
| 5/2/2023 | IMV Inc. | IMV | Downgrade | Neutral (Buy) |
0.82 (0.82) |
0% | Details | |
| 4/28/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2023 | Panbella Therapeutics | PBLA | New Coverage | Buy (N/A) |
0.42 (1.11) |
164.29% | Details | |
| 4/21/2023 | Onconova Therapeutics | ONTX | Upgrade | Buy (N/A) |
0.70 (1.00) |
42.86% | Details | |
| 4/19/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2023 | Aprea | APRE | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | IMV Inc. | IMV | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | VYNE Therapeutics | VYNE | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | OmniAb, Inc. | OABI | New Coverage | Buy (N/A) |
3.88 (4.66) |
20.1% | Details | |
| 1/4/2023 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2022 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | Bionomics Ltd. | BNOX | Downgrade | Neutral (Buy) |
6.80 (0.98) |
-85.59% | Details | |
| 12/14/2022 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2022 | Aravive Inc. | ARAV | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | Alpine Immune Sciences | ALPN | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | Applied Genetic Technologies Corp. | AGTC | Downgrade | Neutral (Buy) |
0.24 (0.39) |
62.5% | Details | |
| 10/19/2022 | Lisata Therapeutics, Inc | LSTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | Akouos | AKUS | Downgrade | Neutral (Buy) |
7.01 (13.29) |
89.59% | Details | |
| 10/10/2022 | Aprea | APRE | New Coverage | Buy (N/A) |
0.68 (5.35) |
686.76% | Details | |
| 9/30/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2022 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2022 | Celldex Therapeutics | CLDX | Maintain | Buy (Buy) |
|
Details | ||
| 7/21/2022 | aTyr Pharma | LIFE | Maintain | Buy (Buy) |
|
Details | ||
| 7/18/2022 | Clene, Inc. | CLNN | New Coverage | Buy (N/A) |
4.50 (0.35) |
-92.22% | Details | |
| 7/14/2022 | Biora Therapeutics | BIOR | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2022 | Humanigen | HGEN | Downgrade | Neutral (Buy) |
2.99 (0.04) |
-98.66% | Details | |
| 7/1/2022 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2022 | Astria Therapeutics | ATXS | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2022 | Humanigen | HGEN | Maintain | Buy (Buy) |
|
Details | ||
| 6/28/2022 | Biophytis SA | BPTS | Maintain | Buy (Buy) |
|
Details | ||
| 6/8/2022 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2022 | Caladrius Biosciences | CLBS | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | Aravive Inc. | ARAV | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | Shattuck Labs | STTK | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | Alpine Immune Sciences | ALPN | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | Biomea Fusion Inc. | BMEA | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2022 | Atreca Inc. | BCEL | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2022 | Biomea Fusion Inc. | BMEA | New Coverage | Buy (Buy) |
4.45 (10.89) |
144.72% | Details | |
| 5/23/2022 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
2.59 (1.48) |
-42.86% | Details | |
| 5/18/2022 | VYNE Therapeutics | VYNE | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2022 | Tempest Therapeutics | TPST | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2022 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2022 | Xenetic Biosciences | XBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2022 | Shattuck Labs | STTK | New Coverage | Buy (N/A) |
3.84 (9.71) |
152.86% | Details | |
| 4/29/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 4/29/2022 | Genocea Biosciences | GNCA | Downgrade | Neutral (Buy) |
0.41 (0.05) |
-87.8% | Details | |
| 4/28/2022 | Sio Gene Therapies | SIOX | Downgrade | Sell (Buy) |
0.60 (0.42) |
-30% | Details | |
| 4/13/2022 | Sierra Oncology Inc | SRRA | Downgrade | Neutral (Buy) |
39.52 (54.99) |
39.14% | Details | |
| 4/13/2022 | Alpine Immune Sciences | ALPN | Maintain | Buy (Buy) |
|
Details | ||
| 4/13/2022 | IMV Inc. | IMV | Maintain | Buy (Buy) |
|
Details | ||
| 4/11/2022 | Genocea Biosciences | GNCA | Maintain | Buy (Buy) |
|
Details | ||
| 4/5/2022 | Alpine Immune Sciences | ALPN | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Mustang Bio | MBIO | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2022 | XOMA, Ltd. | XOMA | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2022 | Aptose Biosciences | APTO | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | Krystal Biotech | KRYS | Maintain | Buy (Buy) |
|
Details | ||
| 3/22/2022 | Nuvectis Pharma | NVCT | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Progenity Inc. | PROG | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Nuvectis Pharma | NVCT | New Coverage | Buy (N/A) |
6.81 (6.74) |
-1.03% | Details | |
| 2/28/2022 | Krystal Biotech | KRYS | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2022 | Mustang Bio | MBIO | Maintain | Buy (Buy) |
|
Details | ||
| 2/18/2022 | Ligand Pharma | LGND | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Palatin Technologies | PTN | Maintain | Buy (Buy) |
|
Details | ||
| 2/4/2022 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 2/1/2022 | Sio Gene Therapies | SIOX | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2022 | Sierra Oncology Inc | SRRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2022 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2022 | Checkpoint Therapeutics | CKPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2022 | VYNE Therapeutics | VYNE | New Coverage | Buy (N/A) |
1.00 (2.25) |
125% | Details | |
| 12/28/2021 | Palatin Technologies | PTN | Maintain | Buy (Buy) |
|
Details | ||
| 12/20/2021 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2021 | VYNE Therapeutics | VYNE | New Coverage | Buy (N/A) |
0.91 (1.00) |
9.89% | Details | |
| 12/1/2021 | BeyondSpring Inc. | BYSI | Downgrade | Neutral (Buy) |
14.23 (1.89) |
-86.72% | Details | |
| 11/29/2021 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2021 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2021 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2021 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2021 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Sierra Oncology Inc | SRRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Caladrius Biosciences | CLBS | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2021 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2021 | Biophytis SA | BPTS | New Coverage | Buy (N/A) |
6.09 (0.28) |
-95.4% | Details | |
| 10/21/2021 | Atreca Inc. | BCEL | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2021 | Sio Gene Therapies | SIOX | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | BiomX | PHGE | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2021 | Progenity Inc. | PROG | New Coverage | Buy (N/A) |
2.04 (0.88) |
-56.86% | Details | |
| 10/11/2021 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2021 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2021 | BeyondSpring Inc. | BYSI | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2021 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2021 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2021 | aTyr Pharma | LIFE | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2021 | Catabasis | CATB | Upgrade | Buy (Neutral) |
8.72 (8.54) |
-2.06% | Details | |
| 8/12/2021 | PDS Biotechnology Corp | PDSB | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2021 | BeyondSpring Inc. | BYSI | Upgrade | Buy (Neutral) |
9.63 (14.23) |
47.77% | Details | |
| 8/3/2021 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2021 | Tempest Therapeutics | TPST | New Coverage | Buy (N/A) |
24.19 (3.11) |
-87.14% | Details | |
| 7/12/2021 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2021 | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2021 | Sierra Oncology Inc | SRRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | BeyondSpring Inc. | BYSI | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/30/2021 | Sio Gene Therapies | SIOX | New Coverage | Buy (N/A) |
2.70 (0.42) |
-84.44% | Details | |
| 4/27/2021 | Akouos | AKUS | New Coverage | Buy (N/A) |
15.03 (13.29) |
-11.58% | Details | |
| 4/12/2021 | Humanigen | HGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2021 | BeyondSpring Inc. | BYSI | Downgrade | Neutral (Buy) |
10.80 (1.89) |
-82.5% | Details | |
| 3/22/2021 | Armata Pharmaceuticals | ARMP | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2021 | Iovanace Biotherapeutics | IOVA | Upgrade | Buy (Neutral) |
32.36 (11.31) |
-65.05% | Details | |
| 3/1/2021 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2021 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2021 | ESSA Pharma | EPIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2021 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2021 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2021 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2021 | Caladrius Biosciences | CLBS | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Alpine Immune Sciences | ALPN | New Coverage | Buy (N/A) |
14.57 (64.49) |
342.62% | Details | |
| 12/16/2020 | BioLineRx | BLRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2020 | Iovanace Biotherapeutics | IOVA | Downgrade | Neutral (Buy) |
50.26 (32.36) |
-35.61% | Details | |
| 12/7/2020 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2020 | Armata Pharmaceuticals | ARMP | New Coverage | Buy (N/A) |
3.11 (2.67) |
-14.15% | Details | |
| 12/7/2020 | BiomX | PHGE | New Coverage | Buy (N/A) |
5.90 (0.28) |
-95.25% | Details | |
| 11/23/2020 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | PDS Biotechnology Corp | PDSB | Upgrade | Buy (Neutral) |
2.04 (2.60) |
27.45% | Details | |
| 11/6/2020 | Humanigen | HGEN | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2020 | Strata Skin Sciences | SSKN | Upgrade | Buy (Neutral) |
1.23 (0.55) |
-55.28% | Details | |
| 10/27/2020 | Catabasis | CATB | Downgrade | Neutral (Buy) |
5.36 (8.54) |
59.33% | Details | |
| 10/19/2020 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2020 | Humanigen | HGEN | New Coverage | Buy (N/A) |
12.03 (0.04) |
-99.67% | Details | |
| 10/8/2020 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2020 | Catabasis | CATB | New Coverage | Buy (N/A) |
6.19 (8.54) |
37.96% | Details | |
| 8/17/2020 | Principia Biopharma | PRNB | Downgrade | Neutral (Buy) |
90.74 (100.05) |
10.26% | Details | |
| 8/17/2020 | aTyr Pharma | LIFE | Upgrade | Buy (Neutral) |
3.81 (1.60) |
-58.01% | Details | |
| 8/13/2020 | Atreca Inc. | BCEL | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | ESSA Pharma | EPIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2020 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2020 | Aravive Inc. | ARAV | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2020 | Aravive Inc. | ARAV | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2020 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2020 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2020 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | BeyondSpring Inc. | BYSI | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2020 | Actinium Pharma | ATNM | New Coverage | Buy (N/A) |
0.22 (6.79) |
2986.36% | Details | |
| 6/2/2020 | Aduro Biotech | ADRO | Maintain | Neutral (N/A) |
|
Details | ||
| 5/15/2020 | Armata Pharmaceuticals | ARMP | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | Kura Oncology | KURA | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2020 | Xenetic Biosciences | XBIO | New Coverage | Buy (N/A) |
0.86 (4.20) |
388.37% | Details | |
| 4/29/2020 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2020 | Atreca Inc. | BCEL | New Coverage | Buy (N/A) |
14.08 (0.15) |
-98.93% | Details | |
| 4/8/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2020 | BeyondSpring Inc. | BYSI | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2020 | BeyondSpring Inc. | BYSI | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2020 | PDS Biotechnology Corp | PDSB | Downgrade | Neutral (Buy) |
0.74 (2.60) |
251.35% | Details | |
| 3/27/2020 | aTyr Pharma | LIFE | Downgrade | Neutral (Buy) |
3.08 (1.60) |
-48.05% | Details | |
| 3/20/2020 | Armata Pharmaceuticals | ARMP | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2020 | Strata Skin Sciences | SSKN | Downgrade | Neutral (Buy) |
1.00 (0.55) |
-45% | Details | |
| 3/11/2020 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2020 | Avid Bioservices | CDMO | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2020 | Principia Biopharma | PRNB | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2020 | Pieris Pharmaceuticals | PIRS | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2020 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2020 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 1/9/2020 | Principia Biopharma | PRNB | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2020 | Principia Biopharma | PRNB | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2019 | Aravive Inc. | ARAV | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2019 | Aravive Inc. | ARAV | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | aTyr Pharma | LIFE | New Coverage | Buy (N/A) |
3.82 (1.60) |
-58.12% | Details | |
| 11/5/2019 | PDS Biotechnology Corp | PDSB | New Coverage | Buy (N/A) |
3.07 (0.74) |
-75.9% | Details | |
| 10/21/2019 | Sophiris Bio | SPHS | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | Principia Biopharma | PRNB | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2019 | Aravive Inc. | ARAV | New Coverage | Buy (N/A) |
6.54 (0.04) |
-99.39% | Details | |
| 9/30/2019 | Dova Pharmaceuticals Inc | DOVA | Downgrade | Neutral (Buy) |
20.19 (28.04) |
38.88% | Details | |
| 9/27/2019 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2019 | Dova Pharmaceuticals Inc | DOVA | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2019 | Fibrocell Science | FCSC | Downgrade | Neutral (Buy) |
1.83 (3.00) |
63.93% | Details | |
| 8/13/2019 | Mustang Bio | MBIO | New Coverage | Buy (N/A) |
2.89 (0.34) |
-88.24% | Details | |
| 8/7/2019 | Rexahn Pharmaceuticals, Inc. | REXN | Downgrade | Neutral (Buy) |
21.19 (1.81) |
-91.46% | Details | |
| 8/6/2019 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2019 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Caladrius Biosciences | CLBS | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2019 | Principia Biopharma | PRNB | New Coverage | Buy (N/A) |
33.20 (100.05) |
201.36% | Details | |
| 6/24/2019 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2019 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2019 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2019 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2019 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2019 | IMV Inc. | IMV | New Coverage | Buy (N/A) |
3.98 (0.82) |
-79.4% | Details | |
| 3/14/2019 | Sophiris Bio | SPHS | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2019 | Celldex Therapeutics | CLDX | Maintain | Buy () |
|
Details | ||
| 2/28/2019 | Genocea Biosciences | GNCA | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Immune Design | IMDZ | Downgrade | Neutral (Buy) |
1.42 (5.85) |
311.97% | Details | |
| 2/21/2019 | BioTime, Inc. | BTX | New Coverage | Buy (N/A) |
1.27 (0.21) |
-83.46% | Details | |
| 1/23/2019 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2019 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2018 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2018 | Dova Pharmaceuticals Inc | DOVA | New Coverage | Buy (N/A) |
6.88 (20.19) |
193.46% | Details | |
| 11/20/2018 | Caladrius Biosciences | CLBS | New Coverage | Buy (N/A) |
4.82 (0.43) |
-91.08% | Details | |
| 11/7/2018 | Pieris Pharmaceuticals | PIRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2018 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2018 | Rexahn Pharmaceuticals Inc. | RNN | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2018 | AmpliPhi Biosciences | APHB | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2018 | Ligand Pharma | LGND | Maintain | Buy (Buy) |
|
Details | ||
| 10/2/2018 | Aduro Biotech | ADRO | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2018 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2018 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2018 | Krystal Biotech | KRYS | New Coverage | Buy (N/A) |
17.00 (158.54) |
832.59% | Details | |
| 9/19/2018 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2018 | Avid Bioservices | CDMO | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2018 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2018 | Sophiris Bio | SPHS | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2018 | Immune Design | IMDZ | New Coverage | Buy (N/A) |
3.40 (1.42) |
-58.24% | Details | |
| 8/17/2018 | Mateon Therapeutics | MATN | Downgrade | Neutral (Buy) |
0.14 (0.26) |
85.71% | Details |
